Welcome!

iPhone Authors: Jnan Dash, Shelly Palmer, Kevin Benedict, Sarah Lake, Onkar Singh

News Feed Item

CloudVisit Telemedicine Debuts New Features at American Psychiatric Association

Integrated Mobile Health, New Telepsychiatry Pricing Models, and Free Windows Tablets for CloudVisit Subscribers at the APA Annual Meeting in New York

COLD SPRING, NY -- (Marketwired) -- 04/30/14 -- CloudVisit Telemedicine will join thousands of mental health professionals at next week's American Psychiatric Association (APA) Annual Meeting in New York City. As part of their ever-expanding telemedicine and telepsychiatry SaaS (software as a service) platform, CloudVisit will debut new, more affordable pricing models, mobile health integration, and free Windows tablets for mobile telepsychiatry.

Through an innovative partnership with IdoApp, CloudVisit now delivers the complete online healthcare solution featuring Bluetooth health monitoring devices, a mobile app and patient portal, and HIPAA-compliant telemedicine. CloudVisit Telemedicine president and CEO, Daniel Gilbert, invites psychiatrists and other industry professionals to visit their booth at the APA this year.

"Along with this exciting, new integration, we look forward to sharing our new pricing models," said Gilbert. "CloudVisit has a foundation in safe, easy to implement telepsychiatry platforms and now we've made them more affordable and tailored than ever. Regardless of the practice size, we can help providers take their patient relationships to the next level."

CloudVisit Connect: Affordable telepsychiatry and a free Windows tablet

CloudVisit makes it easy and risk-free to get started with telepsychiatry by offering a two-week free trial and a pay-as-you-go $100 per month for unlimited sessions. With this contract-free option providers manage their own secure portal including an online availability calendar, provider-controlled session fees, patient appointment requests, HIPAA-compliant video sessions, and exportable session data.

As a special promotion for APA show attendees, new CloudVisit clients who prepay for one full year of CloudVisit Connect -- just $1200 for unlimited sessions -- will receive a free Windows tablet for mobile telepsychiatry.

Integrated Bluetooth health monitoring devices and mobile app

CloudVisit and IdoApp's affordable devices make digital wellness tracking easy for patients and providers. At-home and in-office health data are instantly transmitted to the patient's Apple or Android device and displayed in their personalized mobile app. Patients can measure, track, and analyze their wellness data from anywhere, then use the easy click-and-share feature to forward health information to their provider through CloudVisit's secure patient portal.

"Our expansion into telehealth and mobile devices brings the provider-patient relationship full circle," Gilbert added. "With CloudVisit and IdoApp, it's remarkably easy and affordable to launch a successful online practice."

CloudVisit also offers a more robust telemedicine and telepsychiatry platform, CloudVisit Private Practice, with enhanced features for high definition video, multi-user video chat, direct patient billing, and EMR/EHR-friendly Continuity of Care Record (CCR) data export.

Visit CloudVisit Telemedicine at the American Psychiatric Association Annual Meeting, May 4-6, 2014 at the Jacob K. Javits Convention Center in New York. Booth #649.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2580493

Add to Digg Bookmark with del.icio.us Add to Newsvine

CloudVisit Telemedicine
Daniel Gilbert
CEO, President, and Founder
3182 Route 9, Suite 107A
Cold Spring, New York 10516
Phone: 888-503-3009
http://www.cloudvisittm.com/telepsychiatry-company-contact/

Google+: +Cloudvisittm113
https://plus.google.com/+Cloudvisittm113

Facebook: facebook.com/CloudVisit
https://www.facebook.com/CloudVisit

Twitter: @CloudVisit
https://twitter.com/CloudVisit

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.